Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Our Donors
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

Integrating multi-omics and neuroimaging to dissect crosstalk between the adaptive and innate immune systems in Alzheimer’s disease

Project Overview

Alzheimer’s disease (AD) is the most common cause of dementia, affecting memory, thinking, and daily functioning. AD is characterized by the buildup of two proteins, amyloid-β and tau. Specifically, tau protein is responsible for the loss of brain cells, leading to dementia. In addition to these two proteins, however, studies have also shown that inflammation plays an important role in how the disease develops and progresses. Immune cells in the brain, such as microglia, normally help clear waste and protect neurons. However, when their function is impaired, harmful proteins can accumulate, worsening brain damage. Recent studies also suggest that other immune cells, such as T cells, become activated in AD and may further increase inflammation and brain injury.

Our research aims to understand how these different parts of the immune system interact at various stages of Alzheimer’s disease to drive tau progression. We will combine advanced brain imaging techniques with cutting-edge molecular analyses of cerebrospinal fluid (the fluid surrounding the brain). This will allow us to study how inflammation in the brain relates to the accumulation of tau proteins, as well as to changes in memory and cognition.
By identifying key immune pathways and interactions that drive disease progression, our findings could help uncover new treatment strategies. Drugs that modulate the immune system are already used for other conditions, such as autoimmune diseases, and could potentially be repurposed to slow or prevent AD. Ultimately, this research will deepen our understanding of the biological processes that cause dementia and bring us closer to personalized therapies for people living with AD.

Principal Investigator

Tevy Chan , McGill University

Team Members

Jo Anne Stratton, Montreal Neurological Institute, McGill University

Pedro Rosa-Neto, Douglas Mental Health University Institute

Marcel Seungsu Woo, University Medical Center Hamburg-Eppendorf

Paolo Vitali, McGill University

Jose A. Morais, McGill University Health Centre

Partners and Donors

Krembil Foundation

Project Ongoing

Integrating multi-omics and neuroimaging to dissect crosstalk between the adaptive and innate immune systems in Alzheimer’s disease

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Accelerator Grants: Neurodegeneration x Immunology

  • Province

    Québec

  • Start Date

    2026

  • Total Grant Amount

    $300,000

  • Health Canada Contribution

    $150,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2026 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co